MA23853A1 - Procede de preparation de produits anti-bacteriens a usage pharmaceutique et veterinaire - Google Patents

Procede de preparation de produits anti-bacteriens a usage pharmaceutique et veterinaire

Info

Publication number
MA23853A1
MA23853A1 MA24218A MA24218A MA23853A1 MA 23853 A1 MA23853 A1 MA 23853A1 MA 24218 A MA24218 A MA 24218A MA 24218 A MA24218 A MA 24218A MA 23853 A1 MA23853 A1 MA 23853A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical
preparation
veterinary use
bacterial products
bacterial
Prior art date
Application number
MA24218A
Other languages
English (en)
Inventor
Burton George
Frederick Moss Stephen
John Eglington Alfred
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508957.9A external-priority patent/GB9508957D0/en
Priority claimed from GBGB9508955.3A external-priority patent/GB9508955D0/en
Priority claimed from GBGB9508956.1A external-priority patent/GB9508956D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23853A1 publication Critical patent/MA23853A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24218A 1995-05-03 1996-05-02 Procede de preparation de produits anti-bacteriens a usage pharmaceutique et veterinaire MA23853A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds

Publications (1)

Publication Number Publication Date
MA23853A1 true MA23853A1 (fr) 1996-12-31

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24218A MA23853A1 (fr) 1995-05-03 1996-05-02 Procede de preparation de produits anti-bacteriens a usage pharmaceutique et veterinaire

Country Status (22)

Country Link
EP (1) EP0823910A1 (fr)
JP (1) JPH11504910A (fr)
KR (1) KR19990008355A (fr)
CN (1) CN1185783A (fr)
AR (1) AR005416A1 (fr)
AU (1) AU5813996A (fr)
BG (1) BG102014A (fr)
BR (1) BR9608313A (fr)
CA (1) CA2217990A1 (fr)
CZ (1) CZ347597A3 (fr)
EA (1) EA199700293A1 (fr)
HU (1) HUP9801066A3 (fr)
IL (1) IL118092A0 (fr)
MA (1) MA23853A1 (fr)
MX (1) MX9708421A (fr)
NO (1) NO974994L (fr)
OA (1) OA10632A (fr)
PE (1) PE50697A1 (fr)
PL (1) PL323141A1 (fr)
SK (1) SK146497A3 (fr)
TR (1) TR199701286T1 (fr)
WO (1) WO1996034868A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (fr) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
WO2013157583A1 (fr) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Nouveau composé de carbapénème

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (fr) * 1980-04-30 1986-09-30 Shoji Ikeda Esters d'ampiciline, et leur production
AU7467194A (en) * 1993-08-18 1995-03-14 Sankyo Company Limited Crystalline carbapenem derivatives
CA2175054C (fr) * 1993-10-29 2005-07-12 Steven Coulton Derives de 2-(pyrazol-3-yle)carbapenem

Also Published As

Publication number Publication date
BG102014A (en) 1998-11-30
CN1185783A (zh) 1998-06-24
EA199700293A1 (ru) 1998-06-25
WO1996034868A1 (fr) 1996-11-07
AR005416A1 (es) 1999-06-23
KR19990008355A (ko) 1999-01-25
CA2217990A1 (fr) 1996-11-07
HUP9801066A3 (en) 1999-01-28
CZ347597A3 (cs) 1998-08-12
IL118092A0 (en) 1996-09-12
MX9708421A (es) 1998-02-28
BR9608313A (pt) 1999-01-26
PL323141A1 (en) 1998-03-16
NO974994D0 (no) 1997-10-30
JPH11504910A (ja) 1999-05-11
EP0823910A1 (fr) 1998-02-18
NO974994L (no) 1997-10-30
PE50697A1 (es) 1997-12-18
HUP9801066A2 (hu) 1998-08-28
OA10632A (en) 2002-09-16
TR199701286T1 (xx) 1998-02-21
SK146497A3 (en) 1998-05-06
AU5813996A (en) 1996-11-21

Similar Documents

Publication Publication Date Title
MA23528A1 (fr) Procede de preparation de produits pharmaceutiques
MA22819A1 (fr) Procede de preparation d'un nouveau produit pharmaceutique.
MA22889A1 (fr) Procede de preparation de produits nouveaux
HUP9603112A2 (en) New pharmaceutical formulation and process for its production
AU7107898A (en) Process and apparatus for the preparation of thick-walled ceramic products
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
HU902307D0 (en) Process for producinbg 19-nor-d vitamin compounds having biological effect and pharmaceutical preparatives containing these compounds
NO953657L (no) Nytt farmasöytisk produkt
MA22493A1 (fr) Conditionnement pour produits agrochimiques et procede pour sa production
HK1010116A1 (en) Naphthalene derivatives process for the preparation thereof and intermediates therefor and pharmaceutical compositions comprising them
MA23518A1 (fr) Procede de preparation de produits pharmaceutiques
FR2769854B1 (fr) Nouveau procede d'obtention de microspheres et les produits ainsi realises
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
MA23853A1 (fr) Procede de preparation de produits anti-bacteriens a usage pharmaceutique et veterinaire
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
HU902047D0 (en) Process for the preparation of pharmaceutical product
BR9603252A (pt) Compostos processo para a preparação e uso dos mesmos processo para a produção de composições farmacéuticas composição farmacêutica e produtos farmacêuticos
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
FR2730163B1 (fr) Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
MA24309A1 (fr) Procede pour la preparation de produit pharmaceutique cristallin.
FR2752675B1 (fr) Procede de preparation d'un produit alimentaire
FI960688A0 (fi) Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö sekä niitä sisältäviä lääkkeitä
MA23096A1 (fr) Procede de preparation des precurseurs medicamenteux de 3-acyl-2-oxindole-1-carboxamides anti-inflammatoires
FR2621918B1 (fr) 2',3'-didesoxy-4-thio-uridines, procede de preparation de ces substances et medicaments qui en contiennent